Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000895421-25-000244·MORGAN STANLEY
Schedule 13G ownership disclosure
Taysha Gene Therapies Inc
Common Stock · CUSIP: 877619106
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 17,629,264 · Class: 8.6%
- Morgan Stanley Capital Services LLC
Shares: 14,375,830 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000244
- Form type
- SCHEDULE 13G
- Filer
- MORGAN STANLEY
- CIK
- CIK 895421
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership